Rasonix 20 mg (Capsule (Enteric Coated))

Unit Price: ৳ 8.00 (7 x 8: ৳ 448.00)
Strip Price: ৳ 64.00

Medicine Details

Category Details
Generic Rabeprazole sodium
Company Incepta pharmaceuticals ltd
Also available as
Rasonix 20 mg tablet Rasonix jr 10 mg capsule

Indications

  • Active duodenal ulcer
  • Active benign gastric ulcer
  • Symptomatic erosive or ulcerative gastro-esophageal reflux disease (GERD)
  • Gastro-esophageal Reflux Disease Long-term Management (GERD Maintenance)
  • Symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD)
  • Zollinger-Ellison Syndrome
  • Eradication of Helicobacter pylori in patients with peptic ulcer disease

Pharmacology

  • Suppresses gastric acid secretion by inhibiting the gastric H+/K+-ATPase
  • Characterized as a gastric proton-pump inhibitor

Dosage

  • Recommended oral dose for active duodenal ulcer and active benign gastric ulcer is 20 mg once daily in the morning
  • Recommended oral dose for erosive or ulcerative GERD is 20 mg once daily for four to eight weeks
  • Maintenance dose of rabeprazole sodium can be 20 mg or 10 mg once daily depending upon patient response
  • Dosage for pediatric patients: 5 mg or 10 mg once daily for 12 weeks based on weight
  • Recommended starting dose for Zollinger-Ellison Syndrome is 60 mg once a day
  • Combination therapy for H. pylori eradication: 20 mg rabeprazole sodium twice daily

Administration

  • Tablets should be taken in the morning before eating
  • Tablets should not be chewed or crushed, but should be swallowed whole

Interaction

  • Potential interaction with ketoconazole, itraconazole, and atazanavir
  • No interaction with liquid antacids observed

Contraindications

  • Hypersensitivity to the active substance or excipients
  • Contraindicated in pregnancy and during breastfeeding

Side Effects

  • May cause headache, diarrhea, abdominal pain, vomiting, constipation, dry mouth, altered appetite, muscle pain, drowsiness, dizziness

Pregnancy & Lactation

  • US FDA pregnancy category 'C'
  • No adequate and well-controlled studies in pregnant women
  • Likely excreted in human milk

Precautions & Warnings

  • Malignancy should be excluded prior to commencing treatment
  • Close surveillance for long-term treatment patients
  • Possible increased risk of hip, wrist, and spine fracture
  • Risk of cross-hypersensitivity reactions with other proton pump inhibitors
  • Care needed for patients at risk of osteoporosis
  • Potential for hypomagnesaemia, hypovitaminosis B12, and cutaneous lupus erythematosus
  • Potential interference with laboratory tests

Use in Special Populations

  • No dosage adjustment for renal or hepatic impairment
  • Not recommended for use in children

Overdose Effects

  • Maximum established exposure not exceeding 60 mg twice daily or 160 mg once daily
  • Effects generally minimal, reversible without further medical intervention
  • No specific antidote known, treatment should be symptomatic and supportive

Therapeutic Class

  • Proton Pump Inhibitor

Storage Conditions

  • Keep below 30°C temperature
  • Away from light and moisture
  • Keep out of the reach of children

Chemical Structure

  • Molecular Formula: C18H21N3O3S
  • Chemical Structure: Image available

Common Questions about Rasonix 20 mg Capsule

  • Information about the capsule, its uses, side effects, administration, pregnancy and lactation, overdose, and quick tips

Related Brands